Be a part of 14th International Conference on Eye and Ophthalmology

• Artificial Intelligence & Machine Learning in Ophthalmology: AI-driven diagnostics, predictive analytics, and automated retinal imaging.
• Oculomics & Systemic Health: Retinal biomarkers for cardiovascular, neurodegenerative, and metabolic diseases.
• Tele-Ophthalmology & Digital Health: Expanding access through mobile eye care, virtual clinics, and remote diagnostics.
• Advances in Cataract and Refractive Surgery: Next-gen IOLs, femtosecond lasers, and surgical pearls for precision outcomes.
• Glaucoma: Innovations in Diagnosis and Management: AI tools, slow-release therapeutics, minimally invasive glaucoma surgery (MIGS).
• Retina and Vitreous Disorders: Gene therapies, stem-cell research, and imaging breakthroughs for AMD, DR, and RVO.
• Cornea, External Diseases, and Ocular Surface Innovations: Regenerative medicine, keratoprosthesis, and advances in dry eye management.
• Pediatric Ophthalmology & Myopia Control: Global myopia epidemic, lifestyle interventions, and pharmacologic approaches.
• Neuro-Ophthalmology: Vision and the Brain: Imaging advances, emergency syndromes, and functional diagnostics.
• Ocular Oncology and Pathology: Molecular insights, tumor imaging, and personalized treatment strategies.
• Genetics & Precision Ophthalmology: CRISPR applications, inherited retinal dystrophies, and personalized therapies
•  Innovations in Surgical Ophthalmology: Robotic surgery, 3D visualization, and AR/VR in surgical training.
• Global Eye Health & Preventive Ophthalmology: Tackling preventable blindness, public health strategies, and outreach programs.
• Sustainability in Ophthalmology: Eco-friendly practices in clinics and ORs, sustainable global eye care models.
• Young Ophthalmologists & Future Leaders Forum: Research presentations, mentorship, and innovation pitches from early-career professionals.

The conference will offer participants an opportunity to:

• Discover the latest developments and emerging trends in ophthalmology and vision science.
• Learn about innovative diagnostic, surgical, therapeutic, and digital technologies.
• Explore the growing role of AI and precision medicine in modern eye care.
• Exchange research findings and clinical experiences with an international audience.
• Build professional and academic collaborations across disciplines and countries.
• Engage with experts through keynote presentations, scientific sessions, panel discussions, and interactive forums.
• Explore how technological progress can be integrated with compassionate, patient-centered care.

The global eye care and ophthalmology sector is entering a period of significant transformation, driven by the growing burden of vision impairment, population ageing, technological innovation, and increasing demand for accessible and personalized eye care. According to the World Health Organization (WHO), at least 2.2 billion people globally have near or distance vision impairment, with at least 1 billion cases preventable or yet to be addressed. Cataract and uncorrected refractive error remain the leading causes, while glaucoma, diabetic retinopathy, and age-related macular degeneration continue to create substantial clinical demand.

Technological advancement is becoming a major force shaping the ophthalmology market. Artificial intelligence, advanced ophthalmic imaging, digital diagnostics, teleophthalmology, robotic and minimally invasive procedures, and data-driven clinical decision-making are increasingly influencing screening, diagnosis, treatment planning, and patient monitoring. Recent research indicates that ophthalmic AI is expanding beyond image-based disease detection toward multimodal, workflow-oriented, and clinically translatable applications.

The market is also moving toward precision and personalized medicine, with growing interest in genetics, biomarkers, regenerative therapies, targeted treatments, and individualized surgical approaches. At the same time, unmet needs in cataract surgery, refractive error correction, myopia management, diabetic eye disease, and vision rehabilitation create considerable opportunities for healthcare providers, researchers, technology developers, pharmaceutical companies, and medical-device manufacturers.

Against this evolving landscape, Eye and Vision 2027 provides an important platform for examining emerging market trends, sharing scientific breakthroughs, developing international collaborations, and discussing how innovation can translate into accessible, effective, and compassionate patient-centered eye care.